Safety and short-term efficacy of preoperative FOLFOX therapy in patients with resectable esophageal squamous cell carcinoma who are ineligible for cisplatin.

Toru KadonoShun YamamotoToshiharu HiroseGo IkedaAkihiro OharaMai ItoyamaKazuki YokoyamaYoshitaka HonmaTaiki HashimotoShigeki SekineKoshiro IshiyamaJunya OgumaHiroyuki DaikoKen Kato

Published in: Esophagus : official journal of the Japan Esophageal Society (2022)

Preoperative FOLFOX had a manageable safety profile and showed favorable short-term efficacy in patients with resectable LAESCC who were ineligible for CDDP-containing treatment.

Keyphrases

patients undergoing
locally advanced
metastatic colorectal cancer
liver metastases
squamous cell carcinoma
stem cells
replacement therapy
rectal cancer
bone marrow
cell therapy